ASCENT INDUSTRIES CO. ACNT

Healthcare SIC 2800 - Chemicals & Allied Products NAICS Manufacturing › Chemical Manufacturing derived Nasdaq

Last close 15.26 2026-09-04
Market cap $137.5M 2026-06-30 share count
52-week range 11.86 - 17.92

Valuation FY2025 figures against the last close

P/S1.8x
P/E169.6x
P/FCF—
EV/EBITDA—
Dividend yield—
Diluted EPS0.09

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $74.9M$80.8M$193.2M$262.0M$334.7M$256.0M$305.2M$280.8M$201.1M$138.6M
Cost of revenue $57.7M$70.1M$191.7M$218.7M$273.9M$233.3M$274.4M———
Gross profit $17.2M$10.7M$1.5M$43.3M$60.8M$22.7M$30.8M$51.2M$28.1M$16.9M
R&D $71.0K$0———$500.0K$600.0K$500.0K$600.0K$603.1K
SG&A $23.0M$19.9M$26.7M$27.6M$30.1M$28.7M$32.6M$27.7M$24.9M—
Operating income -$7.0M-$10.8M-$37.4M$14.5M$27.3M-$31.1M-$1.7M$21.2M$2.1M-$8.2M
Interest expense —$418.0K$4.2M$2.7M$1.5M$2.1M$3.8M$2.2M$985.0K$932.6K
Pre-tax income -$5.6M-$10.8M-$41.1M$12.0M$25.5M-$32.0M-$3.8M$16.5M$1.5M-$9.2M
Income tax $22.0K$1.8M$6.9M$5.6M$5.3M$4.7M$727.0K$3.4M$137.0K$2.2M
Net income $867.0K-$13.6M-$26.6M$22.1M$20.2M-$27.3M-$3.0M$13.1M$1.3M-$7.1M
EPS, basic 0.09-1.35-2.632.162.17-2.98-0.34———
EPS, diluted 0.09-1.35-2.632.122.14-2.98-0.34———
Shares, diluted (wtd. avg.) 9.6M10.1M10.1M10.4M9.5M9.1M9.0M8.9M8.7M8.6M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $57.6M$16.1M$1.8M$1.4M$2.0M$236.0K$626.0K$2.2M$14.0K$62.0K
Receivables $10.0M$12.2M$15.1M$33.2M$33.4M$28.2M$35.1M$41.1M$28.7M$18.0M
Inventory $8.7M$5.7M$52.3M$67.7M$103.2M$85.1M$98.2M$114.2M$72.1M$60.8M
Total current assets $83.0M$83.1M$89.4M$170.4M$160.0M$126.9M$147.1M$167.5M$107.6M$97.5M
Property, plant and equipment ——————$40.7M$40.9M$35.1M$27.3M
Goodwill —$0$0$11.4M$12.6M$1.4M$17.6M$9.8M$6.0M$1.4M
Other intangibles $2.8M$3.4M$8.5M$10.0M$14.4M$11.4M$15.7M$9.7M$10.9M$12.3M
Total assets $111.9M$147.2M$163.3M$269.0M$266.0M$207.0M$257.2M$228.4M$159.9M$138.6M
Accounts payable $5.5M$6.8M$16.4M$14.1M$32.3M$19.7M$21.1M$25.1M$24.3M$16.7M
Short-term debt ——$0$2.5M$2.5M$875.0K$4.0M$0—$0
Total current liabilities $12.4M$22.3M$24.8M$33.5M$50.5M$31.1M$40.6M$37.2M$33.3M$32.6M
Long-term debt —$0$0$69.1M$67.9M$60.5M$71.6M$76.4M$25.9M$8.8M
Total liabilities $24.9M$53.7M$55.9M$134.8M$154.4M$126.7M————
Retained earnings $45.8M$44.9M$58.5M$85.1M$63.1M$42.8M$70.6M$69.0M$58.1M$57.9M
Total equity $87.0M$93.5M$107.4M$134.3M$111.6M$80.3M$106.5M$102.5M$89.7M$88.6M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow -$519.0K$14.7M$23.1M$5.6M$19.1M$18.0M$28.6M-$21.2M$2.2M$1.5M
Depreciation and amortisation $1.1M$1.0M$6.2M$6.4M$10.3M$10.6M$11.1M$8.8M$7.7M$6.7M
Stock-based compensation $1.3M$760.0K$1.0M$1.4M$799.0K$1.8M$2.1M$827.0K$638.0K$459.5K
Capital expenditure $1.5M$1.1M$2.9M$3.4M$1.5M$3.7M$4.5M$7.4M$5.3M$3.0M
Investing cash flow $51.0M$905.0K$50.5M-$5.0M-$32.7M$994.0K-$25.7M-$22.7M-$17.4M$17.7M
Financing cash flow -$9.0M-$1.3M-$73.2M-$1.2M$15.4M-$19.4M-$4.5M$46.1M$15.1M-$19.5M
Dividends paid ——————$0$2.2M$1.1M$0
Buybacks $9.1M$1.0M$1.3M$1.3M$0$635.0K$0$0$0$253.9K

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0000095953-26-000040.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. -100M 0 100M 200M 300M 400M Revenue, FY2016: 138.6M Gross profit, FY2016: 16.9M Net income, FY2016: -7.1M Revenue, FY2017: 201.1M Gross profit, FY2017: 28.1M Net income, FY2017: 1.3M Revenue, FY2018: 280.8M Gross profit, FY2018: 51.2M Net income, FY2018: 13.1M Revenue, FY2019: 305.2M Gross profit, FY2019: 30.8M Net income, FY2019: -3M Revenue, FY2020: 256M Gross profit, FY2020: 22.7M Net income, FY2020: -27.3M Revenue, FY2021: 334.7M Gross profit, FY2021: 60.8M Net income, FY2021: 20.2M Revenue, FY2022: 262M Gross profit, FY2022: 43.3M Net income, FY2022: 22.1M Revenue, FY2023: 193.2M Gross profit, FY2023: 1.5M Net income, FY2023: -26.6M Revenue, FY2024: 80.8M Gross profit, FY2024: 10.7M Net income, FY2024: -13.6M Revenue, FY2025: 74.9M Gross profit, FY2025: 17.2M Net income, FY2025: 867K FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue $138.6M $201.1M $280.8M $305.2M $256.0M $334.7M $262.0M $193.2M $80.8M $74.9M
Gross profit $16.9M $28.1M $51.2M $30.8M $22.7M $60.8M $43.3M $1.5M $10.7M $17.2M
Net income -$7.1M $1.3M $13.1M -$3.0M -$27.3M $20.2M $22.1M -$26.6M -$13.6M $867.0K

Recent filings and events

  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
  • Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07
  • Regulation FD disclosure Item 7.01
  • Material agreement signed Item 1.01
  • Acquisition or disposal completed A purchase or sale of a significant business or asset has closed. Item 2.01
  • Results announced Item 2.02
  • Regulation FD disclosure Item 7.01
  • Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
  • Other event Item 8.01

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 2800

TickerCompanyMarket capP/ERevenue growth
SOLS Solstice Advanced Materials Inc. $10.12B 42.8x 3.1%
PRM Perimeter Solutions, Inc. $5.20B — 16.4%
NGVT Ingevity Corp $2.43B — -2.7%
IOSP INNOSPEC INC. $2.31B 20.1x -3.7%
CC Chemours Co $2.30B — 0.4%
OLN OLIN Corp $1.98B — 3.7%
HUN Huntsman CORP $1.69B — -5.8%
FMC FMC CORP $1.62B — -18.3%